MM Russell 2000® Small Cap Index A (MCJAX)

12.66 -0.13  -1.02% Feb 21 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 12.66
Turnover Ratio 16.00%
1 Year Fund Level Flows -28.18M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.39% -1.24% 23
3M 6.16% 4.55% 15
6M 11.64% 11.74% 26
YTD 0.64% 0.35% 30
1Y 7.35% 6.32% 33
3Y 6.73% 6.04% 33
5Y 7.20% 6.73% 39
10Y -- 11.04% --
15Y -- 7.76% --
20Y -- 8.49% --
As of Feb. 21, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.61% 0.61% 0.00%
Stock 99.39% 99.39% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 31, 2019

Region Exposure

Americas 99.42%
North America 99.11%
Latin America 0.31%
Greater Europe 0.38%
United Kingdom 0.04%
Europe Developed 0.24%
Europe Emerging 0.02%
Africa/Middle East 0.09%
Greater Asia 0.20%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.11%
Asia Emerging 0.09%
Market Classification
% Developed Markets 99.87%
% Emerging Markets 0.13%
As of Dec. 31, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.63%
Communication Services 2.53%
Consumer Cyclical 9.75%
Consumer Defensive 3.82%
Energy 3.17%
Financial Services 16.39%
Healthcare 18.23%
Industrials 16.61%
Real Estate 9.04%
Technology 13.16%
Utilities 3.68%
As of Dec. 31, 2019

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 16.69%
Small 70.40%
Micro 12.92%
As of Dec. 31, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 3.50%
Mid Cap Blend 5.99%
Mid Cap Growth 7.95%
Small Cap Value 23.42%
Small Cap Blend 29.44%
Small Cap Growth 29.70%
As of Dec. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
-- E-Mini Russ 2000 Mar20 Xcme 20200320 0.71% -- --
NVCR NovoCure Ltd 0.34% 88.26 -5.04%
MDCO The Medicines Co 0.30% -- --
GNRC Generac Holdings Inc 0.29% 116.19 -0.67%
LITE Lumentum Holdings Inc 0.29% 83.14 -3.66%
TDOC Teladoc Health Inc 0.28% 113.54 -2.04%
ARWR Arrowhead Pharmaceuticals Inc 0.28% 38.49 -3.15%
HAE Haemonetics Corp 0.28% 118.29 -0.98%
VAC Marriott Vacations Worldwide Corp 0.25% 125.56 -1.95%
PFGC Performance Food Group Co 0.25% 52.80 -0.45%
As of Dec. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide investment results approximating (before fees and expenses) the aggregate price and dividend performance of the securities included in the Russell 2000® Index. The fund invests at least 80% (and, typically, substantially all) of its net assets (plus the amount of any borrowings for investment purposes) in the equity securities of companies included in the index, in weightings that approximate the relative composition of the securities contained in the index, and in Russell 2000 Index futures contracts. The index is a widely recognized, unmanaged index representative of common stocks of smaller capitalized U.S. companies.
General
Security Type Mutual Fund
Oldest Share Symbol MCJZX
Equity Style Small Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Blend
Prospectus Objective Small Company
Fund Owner Firm Name MassMutual
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Brent Reeder 7.52 yrs

Share Classes

Symbol Share Class
MCJFX Retirement
MCJIX Inst
MCJSX S
MCJTX Retirement
MCJYX Other
MCJZX Inst

Net Fund Flows

1M -4.989M
3M -2.692M
6M -14.45M
YTD -4.989M
1Y -28.18M
3Y -58.84M
5Y 48.34M
10Y --
As of Jan. 31, 2020

Risk Info

Beta (5Y) 1.163
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 1.001
Daily Value at Risk (VaR) 1% (All) 2.82%
Monthly Value at Risk (VaR) 1% (All) 11.23%

Fundamentals

Dividend Yield TTM (2-21-20) 1.03%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 18.43
Weighted Average Price to Sales Ratio 1.177
Weighted Average Price to Book Ratio 2.073
Weighted Median ROE 5.45%
Weighted Median ROA -0.28%
Forecasted Dividend Yield 1.52%
Forecasted PE Ratio 16.59
Forecasted Price to Sales Ratio 1.089
Forecasted Price to Book Ratio 1.920
Number of Holdings 2005
As of Dec. 31, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.31%
Forecasted Book Value Growth -79.11%
Forecasted Cash Flow Growth 4.82%
Forecasted Earnings Growth 10.86%
Forecasted Revenue Growth 0.98%
As of Dec. 31, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 0.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee 0.25%
Actual Management Fee 0.10%
Administration Fee 0.20%
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load 5.50%
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 7/26/2012
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 2/1/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.